谷歌母公司Alphabet旗下的AI制药企业Isomorphic Labs近日宣布，已与全球制药巨头礼来和诺华达成战略合作，价值可能达到30亿美元。这些合作聚焦于小分子药物的研发，不包括未来药物销售可能产生的特许权使用费。Isomorphic Labs的AI技术将用于加速新药的发现和开发过程，旨在提高研发效率并降低成本。
Title: AI Pharma Firm Secures $3 Billion Collaboration
Keywords: AI Pharma, Strategic Partnership, $3 Billion Valuation
News content:
Alphabet, Google’s parent company, has announced that its AI pharmaceutical company, Isomorphic Labs, has entered into strategic partnerships with global pharmaceutical giants Lilly and Novartis. These collaborations are valued at up to $3 billion and are focused on small molecule drugs, excluding potential royalties from future drug sales. Isomorphic Labs will employ its AI technology to expedite the discovery and development of new drugs, aiming to enhance efficiency and reduce costs in the pharmaceutical industry.
【来源】https://news.cnstock.com/industry,rdjj-202401-5173731.htm
Views: 1